Generic Name and Formulations:
Tavaborole 5%; topical soln; contains alcohol.
Indications for KERYDIN:
Treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
Apply to affected toenail(s) once daily for 48 weeks. Ensure complete application to entire toenail surface and under the tip of each toenail being treated.
Not for oral, ophthalmic, or intravaginal use. Product is flammable. Pregnancy (Cat.C). Nursing mothers.
Ingrown toenail, application site reactions (eg, exfoliation, erythema, dermatitis).
Bottle (10mL)—1 (w. dropper)
Endocrinology Advisor Articles
- Cushing Syndrome Results in Poor Quality of Life Even After Remission
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Link Between Gestational Diabetes and Risk for CVD and Diabetes in Hispanic/Latina Population
- Clinical Characteristics Altering Risks and Benefits of Sulfonylureas and Thiazolidinedione Therapy in T2D
- 6 Factors Related to Inclusion in Health Care Workplace Identified
- Weight Gain After Quitting Smoking May Increase Risk for T2D